At the Institut für Diabetes-Technologie (IfDT), we conduct clinical trials with medical devices in a welcoming, familiar atmosphere and offer our international customers expertise in all parts of clinical studies: starting from planning and designing over conduction up to publishing the study results.
In addition, we perform research on our own behalf regarding different aspects of diabetes.
Taken all this together made us a globally recognized and acknowledged research institute in the area of diabetes technology.
We are happy if you want to actively support us in our research for the benefit of people with diabetes mellitus type 1 or type 2.
Here you can inform yourself about general conditions, procedures and prerequisites for study participation.
Over the years the institute has grown to a worldwide recognized and acknowledged study site. Here you can learn more about our work and the institute.
We are always looking for motivated and committed employees who want to promote technology and research together with us. Here you can read more about the benefits we offer as an employer and our current job offers.
November 2022 - CGM
The accuracy of CGM systems is communicated in the literature by many different ways of presentation, which limits comparability. As part of our collaboration with the Diabetes Center Berne to support the work of the IFCC working group on CGM, we have developed a new statistical method for evaluating and presenting the accuracy of CGM systems. This clearly provides all relevant information for assessing accuracy.
November 2022 - CGM
To demonstrate compliance with US FDA requirements for "integrated" CGM systems, confidence intervals for agreement rates must be calculated. We have identified a suitable method for this and provide a tool for calculation. This work has been done in cooperation with the Diabetes Center Berne in support of the work of the IFCC Working Group on CGM.
October 2022 - Glucose measurement
Comparative measurements, e.g. for CGM studies, can be retrospectively improved by different approaches and thus lead to more consistent study results. We have developed a suitable approach for this within the framework of our cooperation with the Diabetes Center Berne to support the work of the IFCC working group on CGM.
22 - 25 February 2023
Dr. Freckmann gave a presentation on standardization related to CGM systems on Friday, February 24, 2023. He presented the current status of the activities of the IFCC working group on CGM.
26 - 28 January 2023
Some of our colleagues took the opportunity of the Diatec continuing education event to learn about the current state of research in diabetes technology in various lectures, seminars and symposia.
Dr. Guido Freckmann, as part of the diatec team, actively participated in the organization of the conference and gave lectures on "CGM in hospitals" and "Glucose measurement in type 2 diabetes". He also led a seminar on "Safety issues in medical devices".
24 - 26 November 2022
Dr. Freckmann and Dr. Stefan Pleus spoke at the KLD symposium as part of the autumn conference on diabetology & angiology. In the subsequent symposium of the AGDT on the topic of Automatic Insulin Dosing (AID), Dr. Stefan Pleus presented the basics of blood glucose measurement, continuous glucose measurement, and insulin pumps.
We are happy if you want to actively support us in our research for the benefit of people with diabetes type 1 or type 2.
In this way, you are making your own personal contribution to improving medical care.
We are looking forward to meet you!
To improve the reader-friendliness of our website, we use the generic masculine. In the context of equal treatment, we would like to point out that the content of our website is aimed at all genders and does not contain any valuation.
